Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Gene-Metabolite Interaction in the One Carbon Metabolism Pathway: Predictors of Colorectal Cancer in Multi-Ethnic Families.

Shiao SPK, Grayson J, Yu CH.

J Pers Med. 2018 Aug 6;8(3). pii: E26. doi: 10.3390/jpm8030026.

2.

Early Outcome Data Assessing Utility of a Post-Test Genomic Counseling Framework for the Scalable Delivery of Precision Health.

Sturm AC, Schmidlen T, Scheinfeldt L, Hovick S, McElroy JP, Toland AE, Roberts JS, Sweet K.

J Pers Med. 2018 Jul 25;8(3). pii: E25. doi: 10.3390/jpm8030025.

3.

Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey.

Owusu Obeng A, Fei K, Levy KD, Elsey AR, Pollin TI, Ramirez AH, Weitzel KW, Horowitz CR.

J Pers Med. 2018 Jul 24;8(3). pii: E24. doi: 10.3390/jpm8030024.

4.

Preface to Special Issue on 'Cytochrome P450 Variation in Pharmacogenomics'.

Rettie AE, Liggett SB.

J Pers Med. 2018 Jul 4;8(3). pii: E23. doi: 10.3390/jpm8030023. No abstract available.

5.

Warfarin: The End or the End of One Size Fits All Therapy?

Pirmohamed M.

J Pers Med. 2018 Jun 28;8(3). pii: E22. doi: 10.3390/jpm8030022. Review.

6.

Willingness to Participate in a National Precision Medicine Cohort: Attitudes of Chronic Kidney Disease Patients at a Cleveland Public Hospital.

Cooke Bailey JN, Crawford DC, Goldenberg A, Slaven A, Pencak J, Schachere M, Bush WS, Sedor JR, O'Toole JF.

J Pers Med. 2018 Jun 26;8(3). pii: E21. doi: 10.3390/jpm8030021.

7.

ENABLE 2017, the First EUROPEAN PhD and Post-Doc Symposium. Session 3: In Vitro to In Vivo: Modeling Life in 3D.

Di Mauro G, Dondi A, Giangreco G, Hogrebe A, Louer E, Magistrati E, Mullari M, Turon G, Verdurmen W, Cortada HX, Zivanovic S.

J Pers Med. 2018 May 22;8(2). pii: E20. doi: 10.3390/jpm8020020.

8.

Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer.

Lu CY, Loomer S, Ceccarelli R, Mazor KM, Sabin J, Clayton EW, Ginsburg GS, Wu AC.

J Pers Med. 2018 May 16;8(2). pii: E19. doi: 10.3390/jpm8020019.

9.

Correction: Antoniou, M.; et al. Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample Size. J. Pers. Med. 2017, 7, 19.

Antoniou M, Jorgensen AL, Kolamunnage-Dona R.

J Pers Med. 2018 May 7;8(2). pii: E18. doi: 10.3390/jpm8020018. No abstract available.

10.

Correction: Antoniou, M.; et al. Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological Review. J. Pers. Med. 2017, 7, 1.

Antoniou M, Kolamunnage-Dona R, Jorgensen AL.

J Pers Med. 2018 May 7;8(2). pii: E17. doi: 10.3390/jpm8020017. No abstract available.

11.

Applicability of Precision Medicine Approaches to Managing Hypertension in Rural Populations.

Halladay JR, Lenhart KC, Robasky K, Jones W, Homan WF, Cummings DM, Cené CW, Hinderliter AL, Miller CL, Donahue KE, Garcia BA, Keyserling TC, Ammerman AS, Patterson C, DeWalt DA, Johnston LF, Willis MS, Schisler JC.

J Pers Med. 2018 Apr 30;8(2). pii: E16. doi: 10.3390/jpm8020016.

12.

Ten Years' Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics.

Gaedigk A, Dinh JC, Jeong H, Prasad B, Leeder JS.

J Pers Med. 2018 Apr 17;8(2). pii: E15. doi: 10.3390/jpm8020015. Review.

13.

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.

Lozano E, Briz O, Macias RIR, Serrano MA, Marin JJG, Herraez E.

J Pers Med. 2018 Apr 16;8(2). pii: E14. doi: 10.3390/jpm8020014. Review.

14.

Genomic Profiling on an Unselected Solid Tumor Population Reveals a Highly Mutated Wnt/β-Catenin Pathway Associated with Oncogenic EGFR Mutations.

Jiang J, Protopopov A, Sun R, Lyle S, Russell M.

J Pers Med. 2018 Apr 9;8(2). pii: E13. doi: 10.3390/jpm8020013.

15.

Improved Labeling of Pancreatic Islets Using Cationic Magnetoliposomes.

Garcia Ribeiro RS, Ketkar-Atre A, Yin T, Louchami K, Struys T, Lambrichts I, Sener A, Malaisse WJ, De Cuyper M, Himmelreich U.

J Pers Med. 2018 Mar 12;8(1). pii: E12. doi: 10.3390/jpm8010012.

16.

A Genome-Wide Association Study of Idiopathic Dilated Cardiomyopathy in African Americans.

Xu H, Dorn GW 2nd, Shetty A, Parihar A, Dave T, Robinson SW, Gottlieb SS, Donahue MP, Tomaselli GF, Kraus WE, Mitchell BD, Liggett SB.

J Pers Med. 2018 Feb 26;8(1). pii: E11. doi: 10.3390/jpm8010011.

17.

Gene Environment Interactions and Predictors of Colorectal Cancer in Family-Based, Multi-Ethnic Groups.

Shiao SPK, Grayson J, Yu CH, Wasek B, Bottiglieri T.

J Pers Med. 2018 Feb 16;8(1). pii: E10. doi: 10.3390/jpm8010010.

18.

P450 Pharmacogenetics in Indigenous North American Populations.

Henderson LM, Claw KG, Woodahl EL, Robinson RF, Boyer BB, Burke W, Thummel KE.

J Pers Med. 2018 Feb 1;8(1). pii: E9. doi: 10.3390/jpm8010009. Review.

19.

Pharmacogenomic Impact of CYP2C19 Variation on Clopidogrel Therapy in Precision Cardiovascular Medicine.

Brown SA, Pereira N.

J Pers Med. 2018 Jan 30;8(1). pii: E8. doi: 10.3390/jpm8010008. Review.

20.

Genetic Variations in Sweet Taste Receptor Gene Are Related to Chocolate Powder and Dietary Fiber Intake in Obese Children and Adolescents.

Pioltine MB, de Melo ME, Santos AS, Machado AD, Fernandes AE, Fujiwara CT, Cercato C, Mancini MC.

J Pers Med. 2018 Jan 29;8(1). pii: E7. doi: 10.3390/jpm8010007.

Supplemental Content

Loading ...
Support Center